Calliditas Therapeutics Stock (NASDAQ: CALT)
|Day Range14.93 - 15.24||52 Wk Range- - 25.55||Open / Close14.93 / 15.17||Float / Outstanding- / 26.6M|
|Vol / Avg.1.8K / 5.5K||Mkt Cap402M||P/E-||50d Avg. Price17.05|
|Div / Yield-||Payout Ratio-||Total Float-||EPS-7.24|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Calliditas Therapeutics (NASDAQ: CALT) through any online brokerage.
The latest price target for Calliditas Therapeutics (NASDAQ: CALT) was reported by HC Wainwright & Co. on Monday, December 20, 2021. The analyst firm set a price target for 62.00 expecting CALT to rise to within 12 months (a possible 310.60% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $15.1 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Calliditas Therapeutics.
Calliditas Therapeutics’s Q3 earnings are confirmed for Thursday, November 17, 2022.
There is no upcoming split for Calliditas Therapeutics.
Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.